K Takayasu

Summary

Affiliation: National Cancer Center
Country: Japan

Publications

  1. doi request reprint Superselective transarterial chemoembolization for hepatocellular carcinoma. Validation of treatment algorithm proposed by Japanese guidelines
    Kenichi Takayasu
    Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan
    J Hepatol 56:886-92. 2012
  2. doi request reprint Clinical implication of hypovascular hepatocellular carcinoma studied in 4,474 patients with solitary tumour equal or less than 3 cm
    Kenichi Takayasu
    Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan
    Liver Int 33:762-70. 2013
  3. ncbi request reprint Transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: recent progression and perspective
    Kenichi Takayasu
    Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan
    Oncology 84:28-33. 2013
  4. doi request reprint Transarterial chemoembolization for hepatocellular carcinoma over three decades: current progress and perspective
    Kenichi Takayasu
    Department of Diagnostic Radiology, National Cancer Center Hospital, 5 1 1, Tsukiji, 104 0045 Chuo Ku Tokyo, Japan
    Jpn J Clin Oncol 42:247-55. 2012
  5. doi request reprint Superselective transarterial chemoembolization for hepatocellular carcinoma: recent progression and perspective
    Kenichi Takayasu
    Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan
    Oncology 81:105-10. 2011
  6. ncbi request reprint Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients
    Kenichi Takayasu
    Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan
    Gastroenterology 131:461-9. 2006
  7. ncbi request reprint CT Evaluation of the progression of hypoattenuating nodular lesions in virus-related chronic liver disease
    Kenichi Takayasu
    Department of Diagnostic Radiology, National Cancer Center Hospital, 5 1 1, Tsukiji, Chuo Ku, Tokyo 104 0045, Japan
    AJR Am J Roentgenol 187:454-63. 2006
  8. ncbi request reprint CT Imaging of early hepatocellular carcinoma and the natural outcome of hypoattenuating nodular lesions in chronic liver disease
    Kenichi Takayasu
    Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan
    Oncology 72:83-91. 2007
  9. ncbi request reprint Multiple non-tumorous arterioportal shunts due to chronic liver disease mimicking hepatocellular carcinoma: outcomes and the associated elevation of alpha-fetoprotein
    Kenichi Takayasu
    Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan
    J Gastroenterol Hepatol 21:288-94. 2006
  10. ncbi request reprint Imaging of early hepatocellular carcinoma and adenomatous hyperplasia (dysplastic nodules) with dynamic ct and a combination of CT and angiography: experience with resected liver specimens
    Kenichi Takayasu
    Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan
    Intervirology 47:199-208. 2004

Detail Information

Publications31

  1. doi request reprint Superselective transarterial chemoembolization for hepatocellular carcinoma. Validation of treatment algorithm proposed by Japanese guidelines
    Kenichi Takayasu
    Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan
    J Hepatol 56:886-92. 2012
    ..However, the best indication and appropriateness of the algorithm for TACE are still unclear...
  2. doi request reprint Clinical implication of hypovascular hepatocellular carcinoma studied in 4,474 patients with solitary tumour equal or less than 3 cm
    Kenichi Takayasu
    Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan
    Liver Int 33:762-70. 2013
    ..To clarify the biological behaviour of small hypovascular hepatocellular carcinoma (HCC) because of insufficient evidence even though frequently encountered...
  3. ncbi request reprint Transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: recent progression and perspective
    Kenichi Takayasu
    Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan
    Oncology 84:28-33. 2013
    ..Based on these results, the combination of TACE and novel molecular targeted agents can be used to elucidate the synergic effect on survival...
  4. doi request reprint Transarterial chemoembolization for hepatocellular carcinoma over three decades: current progress and perspective
    Kenichi Takayasu
    Department of Diagnostic Radiology, National Cancer Center Hospital, 5 1 1, Tsukiji, 104 0045 Chuo Ku Tokyo, Japan
    Jpn J Clin Oncol 42:247-55. 2012
    ..Moreover, the combination of chemoembolization and molecular targeted agent is now on-going to evaluate the synergistic effect...
  5. doi request reprint Superselective transarterial chemoembolization for hepatocellular carcinoma: recent progression and perspective
    Kenichi Takayasu
    Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan
    Oncology 81:105-10. 2011
    ..Based on these results, the combination of TACE and novel molecular targeted agents can be used to elucidate the synergic effect on survival...
  6. ncbi request reprint Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients
    Kenichi Takayasu
    Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan
    Gastroenterology 131:461-9. 2006
    ..To elucidate the survival of the patients with unresectable hepatocellular carcinoma (HCC) who underwent transcatheter arterial lipiodol chemoembolization (TACE) and to analyze the factors affecting the survivals...
  7. ncbi request reprint CT Evaluation of the progression of hypoattenuating nodular lesions in virus-related chronic liver disease
    Kenichi Takayasu
    Department of Diagnostic Radiology, National Cancer Center Hospital, 5 1 1, Tsukiji, Chuo Ku, Tokyo 104 0045, Japan
    AJR Am J Roentgenol 187:454-63. 2006
    ..The purpose of this study was to clarify the natural outcomes of hypoattenuating nodular lesions in patients with virus-related chronic liver disease depicted on dynamic CT...
  8. ncbi request reprint CT Imaging of early hepatocellular carcinoma and the natural outcome of hypoattenuating nodular lesions in chronic liver disease
    Kenichi Takayasu
    Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan
    Oncology 72:83-91. 2007
    ..The Liver Cancer Study Group of Japan has designated early hepatocellular carcinoma (HCC) a clinically early-stage HCC corresponding to a high-grade dysplastic nodule as proposed by the International Working Party...
  9. ncbi request reprint Multiple non-tumorous arterioportal shunts due to chronic liver disease mimicking hepatocellular carcinoma: outcomes and the associated elevation of alpha-fetoprotein
    Kenichi Takayasu
    Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan
    J Gastroenterol Hepatol 21:288-94. 2006
    ....
  10. ncbi request reprint Imaging of early hepatocellular carcinoma and adenomatous hyperplasia (dysplastic nodules) with dynamic ct and a combination of CT and angiography: experience with resected liver specimens
    Kenichi Takayasu
    Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan
    Intervirology 47:199-208. 2004
    ..Hemodynamic changes in cirrhotic liver were similarly evaluated using CTAP and CTHA, and the treatment of early HCC is briefly discussed herein...
  11. ncbi request reprint Haemodynamic changes in non-alcoholic (viral) liver cirrhosis studied by computed tomography (CT) arterial portography and CT arteriography
    K Takayasu
    Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan
    J Gastroenterol Hepatol 14:908-14. 1999
    ....
  12. ncbi request reprint Neovasculature of benign thrombus of the inferior vena cava demonstrated by computed tomography during hepatic arteriography, mimicking a small hepatocellular carcinoma
    Kenichi Takayasu
    Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan
    Jpn J Clin Oncol 33:44-6. 2003
    ..One should note that the stain shown on angiography does not always suggest that the lesion is localized in the liver and is malignant...
  13. ncbi request reprint Hepatic nodules with early enhancement during computed tomography portography: report of six cases
    Kenichi Takayasu
    Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan
    J Gastroenterol Hepatol 17:779-84. 2002
    ..To study the clinicopathologic characteristics of hepatic nodular lesions with high attenuation (increased portal blood flow) compared with surrounding hepatic parenchyma on computed tomography (CT) during arterial portography (CTAP)...
  14. ncbi request reprint Sensitivity of superselective arteriography for small hepatocellular carcinoma compared with proximal arteriography and computed tomography during superselective arteriography
    Kenichi Takayasu
    Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan
    Jpn J Clin Oncol 32:191-5. 2002
    ....
  15. ncbi request reprint First international symposium of current issues for nationwide survey of primary liver cancer in Korea, Taiwan and Japan
    Kenichi Takayasu
    Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan
    Jpn J Clin Oncol 37:233-40. 2007
  16. ncbi request reprint Targeted transarterial oily chemoembolization for small foci of hepatocellular carcinoma using a unified helical CT and angiography system: analysis of factors affecting local recurrence and survival rates
    K Takayasu
    Department of Diagnostic Radiology, National Cancer Center Hospital, Tsukiji, Chuo-ku, Tokyo 104-0045, Japan
    AJR Am J Roentgenol 176:681-8. 2001
    ..Tumor size along with degree of intratumoral iodized oil deposition and tumor thrombus along with maximum tumor size were significant factors affecting local recurrence and survival rate, respectively...
  17. ncbi request reprint Hepatocellular and cholangiocellular carcinoma, double cancer of the liver: report of two cases resected synchronously and metachronously
    K Takayasu
    Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan
    Am J Gastroenterol 84:544-7. 1989
    ..The histopathological diagnosis of the noncancerous portion was chronic active hepatitis in both cases. However, it changed to precirrhosis in case 2 during the follow-up...
  18. ncbi request reprint Transarterial chemotherapy with zinostatin stimalamer for hepatocellular carcinoma
    T Okusaka
    Department of Internal Medicine, National Cancer Center Hospital, Tokyo, Japan
    Oncology 55:276-83. 1998
    ..Transarterial chemotherapy with SMANCS, which is well tolerated, appears to have moderate antitumor effect in patients with HCC...
  19. ncbi request reprint CT of hilar cholangiocarcinoma: late contrast enhancement in six patients
    K Takayasu
    Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan
    AJR Am J Roentgenol 154:1203-6. 1990
    ....
  20. ncbi request reprint A clinical and radiologic study of primary liver cancer associated with extrahepatic primary cancer
    K Takayasu
    Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan
    Cancer 69:45-51. 1992
    ..5% at 3 years, and 40.5% and 40.1% at 5 years, respectively. There was no significant difference between the survival rates of those who underwent operations for PLC and extrahepatic primary cancer(s) synchronously and metachronously...
  21. doi request reprint Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis
    Kenichi Takayasu
    Department of Diagnostic Radiology, National Cancer Center Hospital, 5 1 1, Tsukiji, Chuo Ku, Tokyo 104 0045, Japan
    AJR Am J Roentgenol 194:830-7. 2010
    ..The purpose of this study was to determine whether one of these therapies is superior to the other or the two are equal in survival benefit and whether embolization with gelatin sponge particles is indispensable to prolonging survival...
  22. doi request reprint Chemoembolization for unresectable hepatocellular carcinoma in Japan
    Kenichi Takayasu
    Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan ktakayas ncc go jp
    Oncology 78:135-41. 2010
    ..The modified version of the assessment criteria of the TE of treatment for liver cancer was proposed by the LCSGJ in 2009, using a 4-grade treatment effect with two factors of tumor necrosis and tumor regression...
  23. ncbi request reprint Analysis of prognostic factors affecting survival after initial recurrence and treatment efficacy for recurrence in patients undergoing potentially curative hepatectomy for hepatocellular carcinoma
    Kazuaki Shimada
    Division of Hepatobiliary and Pancreatic Surgery, National Cancer Center Hospital, Tokyo, Japan
    Ann Surg Oncol 14:2337-47. 2007
    ..In addition, selections of the most effective treatments for patients with recurrent HCC still remain controversial...
  24. ncbi request reprint Transcatheter arterial embolization with zinostatin stimalamer for hepatocellular carcinoma
    Takuji Okusaka
    Hepatobiliary and Pancreatic Oncology Division, National Cancer Center Hospital, Tokyo, Japan
    Oncology 62:228-33. 2002
    ..Grade 3 and 4 non-hematological toxicity (liver dysfunction) occurred in 17 (34%) and 7 patients (14%), respectively. TAE using SMANCS, which was well tolerated, may be an effective treatment for advanced HCC...
  25. ncbi request reprint Prognostic factors in patients with hepatocellular carcinoma treated by transcatheter arterial embolization
    Masafumi Ikeda
    Division of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan
    Jpn J Clin Oncol 32:455-60. 2002
    ..This study investigated prognostic factors in patients with advanced hepatocellular carcinoma treated by transcatheter arterial embolization...
  26. doi request reprint Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: a preliminary report of the Japanese nationwide survey
    Kiyoshi Hasegawa
    Department of Surgery, Japanese Red Cross Medical Center, Tokyo, Japan
    J Hepatol 49:589-94. 2008
    ..The treatment of choice for HCC remains controversial. We evaluated the therapeutic impact of surgical resection, PEI, and RFA for HCC on outcomes...
  27. ncbi request reprint Late complication of a large simple cyst of the liver mimicking cystadenocarcinoma after sclerotherapy
    Kenichi Takayasu
    Department of Diagnostic Radiology, National Cancer Center Hospital, 5 1 1, Tsukiji, Chuo Ku, Tokyo, 104 0045 Japan
    AJR Am J Roentgenol 181:464-6. 2003
  28. ncbi request reprint Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey
    Iwao Ikai
    Department of Gastroenterological Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan
    Cancer 101:796-802. 2004
    ..The objective of this study was to evaluate prognostic predictors for patients with HCC who underwent liver resection in a Japanese nationwide data base...
  29. ncbi request reprint A modified Japan Integrated Stage score for prognostic assessment in patients with hepatocellular carcinoma
    Iwao Ikai
    Department of Gastroenterological Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan
    J Gastroenterol 41:884-92. 2006
    ..This study sought to provide a modified Japan Integrated Stage (m-JIS) score to predict more accurately the survival of patients with HCC...
  30. doi request reprint Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey
    Susumu Eguchi
    Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
    Surgery 143:469-75. 2008
    ..Although a surgical resection is an important modality for the treatment of hepatocellular carcinoma (HCC), the impact of the operative method on both the patient survival and disease-free survival (DFS) still remains controversial...
  31. ncbi request reprint Primary hepatocellular carcinoma detected long after tumor markers and lymph node metastases--beyond our vision?
    Jee Fu Huang
    Department of Internal Medicine, Fooyin University Hospital, Pingtung, Taiwan
    Dig Dis Sci 51:610-5. 2006